Standards of Care in the Frontline Treatment of ER+/HER2- mBC

Komal Jhaveri, MD, FACP, explains data on the frontline standard of care treatment approaches for ER-positive HER2-negative mBC.

Related Videos
Nathalie McDowell Johnson, MD, FACS
William M. Sikov, MD
Lisa A. Carey MD, ScM, FASCO
Susan Domchek, MD, FASCO
Ruth M. O’Regan, MD, professor, chair, Charles Ayrault Dewey Professorship of Medicine, Department of Medicine, the University of Rochester, physician-in-chief, Strong Memorial Hospital, associate director, Education and Mentoring, the Wilmot Cancer Institute at University of Rochester,
Jean Wright, MD
Steven Cai, MD, FACS
Hyman B. Muss, MD
Expert on breast cancer
Priyanka Sharma, MD
Related Content